Skip to main content

Table 1 Characteristics of 87 patients with locoregional recurrent esophageal cancer

From: Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis

Variables Number Percent
Age (years)
  < 65 58 66.7
  ≥ 65 29 33.3
KPS
 70–80 32 36.8
 >80 55 63.2
Gender
 Male 65 74.7
 Female 22 25.3
Smoking
 Yes 31 35.6
 No 56 64.4
Alcohol consumption
 Yes 15 17.2
 No 72 82.8
Primary tumor location
 Upper thoracic 34 39.1
 Middle and lower thoracic 53 60.9
Initial clinical stage
 I + II 23 32.9
 III 47 67.1
Initial treatment
 Surgery + adjuvant radio(chemo)therapy 11 12.6
 Definitive chemoradiotherapy 39 44.8
 Definitive radiotherapy 37 42.6
Pattern of recurrence
 Regional lymph node recurrence only 14 16.1
 Local failure 62 71.3
 Both 11 12.6
Radiation dose in the initial treatment (Gy)
  ≤ 50 12 13.8
  > 50 75 86.2
Recurrence-free interval (months)
  ≤ 12 38 43.7
  > 12 49 56.3
Chemotherapy after recurrence
 Yes 26 29.9
 No 61 70.1
Re-RT after recurrence
 Yes 39 44.8
 No 48 55.2
Treatment moditily after recurrence
 Re-RT only 20 23.0
 CRT only 7 8.0
 Re-RT concomitant chemotherapy 19 21.8
 Best supportive care 39 43.7
 Salvage total esophagectomy 3 3.4
  1. Abbreviation: Re-RT Re-irradiation, KPS Karnofsky performance status